Richlocaine in combined therapy of periodontitis.
The results of combined therapy of chronic moderate generalized periodontitis can be improved by adding richlocaine to protocols of drug therapy: the drug reduces the time of treatment, prolongs remission, decreases the number of relapses, and stabilizes pathological processes in periodontal tissues.
Popkov
V I
VI
Kuban' State Medical Academy, Krasnodar Research Center, Russian Academy of Medical Sciences and Administration of the Krasnodar Territory.
Zadorozhnyi
A V
AV
Galenko-Yaroshevskii
P A
PA
D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010518:Periodontitis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control*; D010880:Piperidines / Q000627:therapeutic use*; D011859:Radiography; D055502:Secondary Prevention
D000700:Analgesics; D000900:Anti-Bacterial Agents; D010880:Piperidines; C493511:richlocaine